US heart doctors defend new prevention guidelinesBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f6957 (Published 20 November 2013) Cite this as: BMJ 2013;347:f6957
- Michael McCarthy
The American Health Association and the American College of Cardiology have defended their new prevention guidelines after critics charged that a risk assessment tool included in the document might put millions of Americans on cholesterol lowering drugs unnecessarily.
“We stand behind our guidelines [and] the process that was used to create them,” said Mariell Jessup, president of the American Heart Association, in a statement issued in response to the criticism, which has been reported widely in the US media.
At issue is a risk calculator designed to help guide the decision whether a patient should be prescribed a statin, by estimating the patient’s 10 year risk of having a heart attack …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial